Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,969.34
+20.63(+0.35%)
Dow 30
44,296.51
+426.16(+0.97%)
Nasdaq
19,003.65
+31.23(+0.16%)
Russell 2000
2,406.67
+42.65(+1.80%)
Crude Oil
71.18
+1.08(+1.54%)
Gold
2,718.20
+43.30(+1.62%)

HCW Biologics Inc. (HCWB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

0.7700

+0.0604

(+8.51%)

At close: 04:00PM EST

0.7600

-0.01

(-1.30%)

After hours:

07:59PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	32.33M
Enterprise Value	44.13M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	8.20
Price/Book (mrq)	2.80
Enterprise Value/Revenue	12.62
Enterprise Value/EBITDA	-3.63

Trading Information

Stock Price History

Beta (5Y Monthly)	0.84
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	2.5200
52 Week Low ³	0.2760
50-Day Moving Average ³	0.5273
200-Day Moving Average ³	0.9273

Share Statistics

Avg Vol (3 month) ³	9.17M
Avg Vol (10 day) ³	57.58M
Shares Outstanding ⁵	41.98M
Implied Shares Outstanding ⁶	N/A
Float ⁸	17.85M
% Held by Insiders ¹	52.30%
% Held by Institutions ¹	3.13%
Shares Short (Oct 31, 2024) ⁴	8.09k
Short Ratio (Oct 31, 2024) ⁴	0.28
Short % of Float (Oct 31, 2024) ⁴	0.04%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	0.02%
Shares Short (prior month Sep 30, 2024) ⁴	28.05k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-2,235.75%

Management Effectiveness

Return on Assets (ttm)	-70.09%
Return on Equity (ttm)	-344.32%

Income Statement

Revenue (ttm)	3.92M
Revenue Per Share (ttm)	0.11
Quarterly Revenue Growth (yoy)	-0.60%
Gross Profit (ttm)	N/A
EBITDA	-36.58M
Net Income Avi to Common (ttm)	-38.37M
Diluted EPS (ttm)	-1.0100
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	1.16M
Total Cash Per Share (mrq)	0.03
Total Debt (mrq)	10.02M
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.10
Book Value Per Share (mrq)	0.37

Cash Flow Statement

Operating Cash Flow (ttm)	-17.95M
Levered Free Cash Flow (ttm)	-6.03M